• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者发生肺栓塞和深静脉血栓的风险:一项基于英国人群的门诊队列研究。

The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study.

机构信息

Section of Rheumatology, Boston University School of Medicine, Boston, MA 02118, USA.

出版信息

Ann Rheum Dis. 2013 Jul;72(7):1182-7. doi: 10.1136/annrheumdis-2012-201669. Epub 2012 Aug 28.

DOI:10.1136/annrheumdis-2012-201669
PMID:22930596
Abstract

BACKGROUND

Recent hospital-based studies have suggested a sixfold increased risk of pulmonary embolism (PE) in rheumatoid arthritis (RA) in the year following admission. We evaluated the risk of PE and deep vein thrombosis (DVT) and associated time trend among RA patients (84.5% without a history of hospitalisation during the past year) derived from the general population.

METHODS

We conducted a cohort study using an electronic medical records database representative of the UK general population, collected from 1986 to 2010. Primary definitions of the RA cohort (exposure) and PE/DVT outcomes required physician diagnoses followed by corresponding treatments. We estimated relative risks (RRs) of PE and DVT compared with a matched non-RA comparison cohort, adjusting for age, sex, smoking, body mass index, comorbidities and hospitalisations.

RESULTS

Among 9589 individuals with RA (69% female, mean age of 58 years), 82 developed PE and 110 developed DVT (incidence rates, 1.5 and 2.1 per 1000 person-years). Compared with non-RA individuals (N=95 776), the age-, sex- and entry-time-matched RRs were 2.23 (95% CI 1.75 to 2.86) for PE and 2.20 (CI 1.78 to 2.71) for DVT. Adjusting for other covariates, the corresponding RRs were 2.16 (CI 1.68 to 2.79) and 2.16 (CI 1.74 to 2.69). The time-specific RRs for PE were 3.27, 1.88 and 2.35 for follow-up times of <1 year, 1-4.9 years, and ≥5 years, and corresponding RRs for DVT were 3.16, 1.82 and 2.32.

CONCLUSIONS

This population-based study indicates an increased risk of PE and DVT in RA, supporting increased monitoring of venous-thromboembolic complications and risk factors in RA, regardless of hospitalisation.

摘要

背景

最近的基于医院的研究表明,在入院后一年内,类风湿关节炎(RA)患者发生肺栓塞(PE)的风险增加了六倍。我们评估了来自普通人群的 RA 患者(84.5%在过去一年中没有住院史)中 PE 和深静脉血栓形成(DVT)的风险以及相关的时间趋势。

方法

我们使用从 1986 年至 2010 年收集的代表英国普通人群的电子病历数据库进行了队列研究。RA 队列(暴露)和 PE/DVT 结果的主要定义需要医生诊断,随后需要相应的治疗。我们估计了与匹配的非 RA 对照组相比,PE 和 DVT 的相对风险(RR),调整了年龄、性别、吸烟、体重指数、合并症和住院情况。

结果

在 9589 名 RA 患者(69%为女性,平均年龄为 58 岁)中,有 82 人发生了 PE,110 人发生了 DVT(发病率分别为 1.5 和 2.1/1000 人年)。与非 RA 个体(N=95776)相比,年龄、性别和入组时间匹配的 RR 分别为 2.23(95%CI 1.75 至 2.86)用于 PE 和 2.20(CI 1.78 至 2.71)用于 DVT。调整其他协变量后,相应的 RR 分别为 2.16(CI 1.68 至 2.79)和 2.16(CI 1.74 至 2.69)。PE 的时间特异性 RR 分别为<1 年、1-4.9 年和≥5 年随访时间的 3.27、1.88 和 2.35,相应的 DVT RR 分别为 3.16、1.82 和 2.32。

结论

这项基于人群的研究表明 RA 患者发生 PE 和 DVT 的风险增加,支持无论是否住院,RA 患者都应加强静脉血栓栓塞并发症和危险因素的监测。

相似文献

1
The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study.类风湿关节炎患者发生肺栓塞和深静脉血栓的风险:一项基于英国人群的门诊队列研究。
Ann Rheum Dis. 2013 Jul;72(7):1182-7. doi: 10.1136/annrheumdis-2012-201669. Epub 2012 Aug 28.
2
The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study.类风湿关节炎患者肺栓塞和深静脉血栓形成的风险和趋势:一项基于普通人群的研究。
Rheumatology (Oxford). 2021 Jan 5;60(1):188-195. doi: 10.1093/rheumatology/keaa262.
3
Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study.类风湿性关节炎增加深静脉血栓和肺血栓栓塞症的风险:一项全国性队列研究。
Ann Rheum Dis. 2014 Oct;73(10):1774-80. doi: 10.1136/annrheumdis-2013-203380. Epub 2013 Aug 7.
4
Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.在一个多机构医疗系统中,2019冠状病毒病检测呈阳性的住院患者发生深静脉血栓形成和肺栓塞预示着更高的死亡率以及更长的重症监护病房住院时间和医院住院时间。
J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1361-1370.e1. doi: 10.1016/j.jvsv.2021.03.009. Epub 2021 Apr 6.
5
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.炎症性肠病患者深静脉血栓形成和肺栓塞的发病率:一项基于人群的队列研究。
Thromb Haemost. 2001 Mar;85(3):430-4.
6
Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study.系统性红斑狼疮增加深静脉血栓形成和肺栓塞的风险:一项全国性队列研究。
J Thromb Haemost. 2014 Apr;12(4):452-8. doi: 10.1111/jth.12518.
7
Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study.糖尿病会增加深静脉血栓形成和肺栓塞的风险。一项基于人群的队列研究。
Thromb Haemost. 2015 Oct;114(4):812-8. doi: 10.1160/TH14-10-0868. Epub 2015 Aug 13.
8
Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis.巴瑞替尼治疗类风湿关节炎的心血管安全性。
Arthritis Rheumatol. 2019 Jul;71(7):1042-1055. doi: 10.1002/art.40841. Epub 2019 May 25.
9
Inflammatory bowel disease increases the risks of deep vein thrombosis and pulmonary embolism in the hospitalized patients: a nationwide cohort study.炎症性肠病增加住院患者深静脉血栓形成和肺栓塞的风险:一项全国性队列研究。
Thromb Res. 2015 Mar;135(3):492-6. doi: 10.1016/j.thromres.2014.12.025. Epub 2015 Jan 7.
10
Is Obesity Associated With Increased Risk of Deep Vein Thrombosis or Pulmonary Embolism After Hip and Knee Arthroplasty? A Large Database Study.肥胖是否与髋关节和膝关节置换术后深静脉血栓形成或肺栓塞风险增加相关?一项大型数据库研究。
Clin Orthop Relat Res. 2019 Mar;477(3):523-532. doi: 10.1097/CORR.0000000000000615.

引用本文的文献

1
The Inflammatory Link of Rheumatoid Arthritis and Thrombosis: Pathogenic Molecular Circuits and Treatment Approaches.类风湿关节炎与血栓形成的炎症关联:致病分子机制及治疗方法
Curr Issues Mol Biol. 2025 Apr 18;47(4):291. doi: 10.3390/cimb47040291.
2
Risk Factors for Adverse Outcomes in Connective Tissue Disease-Associated Pulmonary Hypertension.结缔组织病相关肺动脉高压不良结局的危险因素
Rev Cardiovasc Med. 2025 Mar 17;26(3):26877. doi: 10.31083/RCM26877. eCollection 2025 Mar.
3
Anti-OJ Antibody-positive Antisynthetase Myopathy Diagnosed after Pulmonary Embolization.
肺栓塞后诊断的抗OJ抗体阳性抗合成酶肌病
Intern Med. 2025 Jun 1;64(11):1750-1755. doi: 10.2169/internalmedicine.4201-24. Epub 2024 Nov 8.
4
A systematic review and meta-analysis of the association between the D-dimer and rheumatic diseases.D-二聚体与风湿性疾病关联的系统评价和荟萃分析。
Immun Inflamm Dis. 2024 Jul;12(7):e1349. doi: 10.1002/iid3.1349.
5
Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs.生物制剂或 Janus 激酶抑制剂在常规抗风湿药物反应不足的类风湿关节炎患者中的应用。
Drugs. 2024 Aug;84(8):877-894. doi: 10.1007/s40265-024-02059-8. Epub 2024 Jul 1.
6
Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database.在类风湿关节炎患者中,与生物疾病修正抗风湿药物相比,使用 Janus 激酶抑制剂治疗会增加心血管事件的风险:一项使用日本健康保险数据库的回顾性纵向基于人群的研究。
RMD Open. 2024 Jun 17;10(2):e003885. doi: 10.1136/rmdopen-2023-003885.
7
[Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis].[类风湿关节炎患者深静脉血栓形成的发病率及危险因素]
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Apr 18;56(2):279-283. doi: 10.19723/j.issn.1671-167X.2024.02.012.
8
Pulmonary Embolism in a Patient with Rheumatoid Arthritis on Etanercept Therapy.一名接受依那西普治疗的类风湿关节炎患者发生肺栓塞
J Community Hosp Intern Med Perspect. 2024 Jan 12;14(1):39-42. doi: 10.55729/2000-9666.1294. eCollection 2024.
9
JAK-Inhibitors - A Story of Success and Adverse Events.JAK抑制剂——成功与不良事件的故事
Open Access Rheumatol. 2024 Feb 26;16:43-53. doi: 10.2147/OARRR.S436637. eCollection 2024.
10
Risk of venous thromboembolism in patients with rheumatoid arthritis: a meta-analysis of observational studies.类风湿关节炎患者发生静脉血栓栓塞的风险:观察性研究的荟萃分析
BMC Rheumatol. 2024 Feb 2;8(1):5. doi: 10.1186/s41927-024-00376-9.